List view / Grid view
23 November 2015 | By Victoria White
The Ross Fund includes £115 million to develop new drugs, diagnostics and insecticides for malaria, TB and other infectious disease resistance...
23 November 2015 | By Victoria White
Evgen has said it will use its Sulforadex platform to synthesise and stabilise the newly acquired compounds with a view to taking the most promising into clinical development...
23 November 2015 | By Victoria White
Cobra will be using its cell line development service, maxXpress, to produce the growth hormone antagonist fusion protein...
20 November 2015 | By Victoria White
Researchers have shown that the gene that causes Huntington's diseases makes an unexpected "cocktail" of mutant proteins that build up in regions of the brain that are most affected by the disease...
20 November 2015 | By Victoria White
The company has announced three new partnerships that will deliver a collaborative screening platform, space-age robotics, and sound waves that can move liquids...
20 November 2015 | By Victoria White
The technology has already been successfully tested in the laboratory. If it works in patients, the therapy could one day revolutionise treatment for many forms of cancer...
20 November 2015 | By Victoria White
The compound exchange represents a novel, open innovation model of collaboration between the two companies.
19 November 2015 | By Victoria White
GeneOne Life Science and Inovio are co-developing the vaccine and plan to initiate the first human trial of a MERS vaccine before the end of the year...
19 November 2015 | By Victoria White
Scientists have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue...
19 November 2015 | By Victoria White
A new study suggests that gamma interferon, which is an FDA-approved drug, may have potential as an antiviral therapy to prevent Ebola infection when given either before or after exposure to the virus...
19 November 2015 | By Victoria White
Researchers have unveiled the 3-D structure of human heparanase - a sugar-degrading enzyme which has received significant attention as a key target in anti-cancer treatments...
18 November 2015 | By Victoria White
The newly discovered virus, known as Parramatta River virus, infects only mosquitoes and does not pose any direct health risks to people...
18 November 2015 | By Victoria White
miR-124 hit multiple targets, reducing androgen receptor signalling and reviving the potency of advanced prostate cancer treatment Xtandi (enzalutamide)...
18 November 2015 | By Victoria White
When studying prototype antibodies that target a specific weak spot on HIV, the researchers noted two of the antibodies had an unusual feature that could prove important in vaccine design...
18 November 2015 | By Victoria White
Morphotek and the TAT Group will investigate farletuzumab as an alpha therapy vector for radioimmunotherapy in ovarian cancer...
